Showing results (201-210 of 478) with videos related to
Sort By:
Pageof 48
Bioorganic & Medicinal Chemistry|May 4, 2012
Synthesis and biological evaluation of a class of 5-benzylidene-2-phenyl-thiazolinones as potent 5-lipoxygenase inhibitorsSebastian Barzen, Carmen B Rödl, Andreas Lill, et al.Chemical Biology & Drug Design|December 27, 2018
Histamine H3 receptor ligands by hybrid virtual screening, docking, molecular dynamics simulations, and investigation of their biological effectsNakisa Ghamari, Omid Zarei, David Reiner, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|October 11, 2014
A search for functional histamine H4 receptors in the human, guinea pig and mouse brainMonika Feliszek, Valerie Speckmann, Daniel Schacht, et al.Reproductive Sciences (Thousand Oaks, Calif.)|September 25, 2015
Effects of the Oral Oxytocin Receptor Antagonist Tocolytic OBE001 on Reproduction in RatsOliver Pohl, Deborah Perks, Jon Rhodes, et al.Pharmaceuticals (Basel, Switzerland)|August 26, 2022
Experimental Studies Indicate That ST-2223, the Antagonist of Histamine H3 and Dopamine D2/D3 Receptors, Restores Social Deficits and Neurotransmission Dysregulation in Mouse Model of AutismNermin Eissa, Karthikkumar Venkatachalam, Petrilla Jayaprakash, et al.Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|June 26, 2017
From medicinal plant extracts to defined chemical compounds targeting the histamine H4 receptor: Curcuma longa in the treatment of inflammationAnnika Frank, Saleh Abu-Lafi, Azmi Adawi, et al.Archiv Der Pharmazie|April 4, 2007
N-(4-(4-(2-Halogenophenyl)piperazin-1-yl)butyl) substituted cinnamoyl amide derivatives as dopamine D2 and D3 receptor ligandsOliver Saur, Anneke E Hackling, Sylvie Perachon, et al.Trends in Cell Biology|November 29, 2018
Posing the APC/C E3 Ubiquitin Ligase to Orchestrate Cell DivisionEdmond R Watson, Nicholas G Brown, Jan-Michael Peters, et al.Frontiers in Neuroscience|October 21, 2016
Dopamine D3 Receptor Antagonists as Potential Therapeutics for the Treatment of Neurological DiseasesSamuele Maramai, Sandra Gemma, Simone Brogi, et al.Bioorganic & Medicinal Chemistry|February 10, 2006
Ether derivatives of 3-piperidinopropan-1-ol as non-imidazole histamine H3 receptor antagonistsDorota Łazewska, Xavier Ligneau, Jean-Charles Schwartz, et al.Pageof 48